Summary
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.59.
Kestra Medical Technologies Q4 Earnings Call Highlights
Kestra Medical Technologies NASDAQ: KMTS reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company's ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetration of existing customers and expansion of its commercial team.
Kestra Medical Technologies, Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 3 | $80 | $72.34 | -$7.66 | -9.57% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 13,626 | $271,566.18 | $326,229.6 | $54,663.42 | 20.13% |
 Joseph Castro Nuveen LLC | 31,877 | $619,283.53 | $773,017.25 | $153,733.72 | 24.82% |
| TC Thomas Cagna Sandia Investment Management LP | 653 | $17,317.56 | $16,066.93 | -$1,250.63 | -7.22% |
| RO Regan O'Neill Burkehill Global Management LP | 50,000 | $1.33M | $1.23M | -$96,600 | -7.29% |
Kestra Medical Technologies, Ltd. (KMTS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Kestra Medical Technologies, Ltd. ever had a stock split?
Kestra Medical Technologies, Ltd. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Brian Webster CEO | NASDAQ (NGS) Exchange | G52441105 CUSIP |
| US Country | 300 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Kestra Medical Technologies, Ltd. is a pioneering company in the realm of wearable medical devices and digital healthcare solutions, rooted in the mission to enhance patient outcomes specifically regarding cardiovascular diseases. The organization was founded in 2014 and is located in Kirkland, Washington. Through the integration of innovative monitoring and therapeutic intervention technologies that are designed to be intuitive, intelligent, and connected, Kestra aims to revolutionize how cardiology is approached. The company centers its efforts on its flagship product, the Cardiac Recovery System platform, which unifies monitoring, therapeutic treatment, digital health, and patient support services into a comprehensive solution for managing cardiac health.
Products and Services
Kestra Medical Technologies offers an array of products and services designed to improve patient engagement and outcomes in the context of cardiovascular care. Below are the key components of their product offering:
- Cardiac Recovery System Platform
The core of Kestra's offerings is the Cardiac Recovery System platform, which integrates advanced monitoring and therapeutic solutions tailored for patients at risk of heart-related incidents. This platform is geared towards creating a seamless experience for both patients and healthcare providers.
- ASSURE Wearable Cardioverter Defibrillator (WCD)
This device is an essential feature of the Cardiac Recovery System, designed specifically for patients who are at an increased risk of sudden cardiac arrest (SCA). It provides life-saving capabilities by continuously monitoring the heart's rhythms and delivering shock therapy when necessary, thereby protecting patients in critical situations.
- Integrated Digital Solutions
Kestra also provides a suite of digital solutions that enhance patient and provider engagement. These tools facilitate real-time communication and support, allowing for proactive management of patient care and more informed decision-making by health professionals.
- Patient Support Services
The company's offerings go beyond technology; they include robust patient support services aimed at ensuring adherence to therapy and providing guidance throughout the recovery process. This holistic approach is designed to empower patients in managing their cardiovascular health effectively.
